Heron Therapeutics Announces Positive Phase 2 Results For Post-Operative Pain

Shares of Heron Therapeutics were up 22% in after hours trade after announcing positive phase 2 results for post-operative pain.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.